First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world - Wikidata - awgldk - TriplyDB

First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world

First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world

http://www.wikidata.org/entity/Q30417939

about

"Stormy waters ahead": global emergence of carbapenemases Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia Characterization of Carbapenem-Resistant Enterobacteriaceae with High Rate of Autochthonous Transmission in the Arabian Peninsula Nested Russian Doll-Like Genetic Mobility Drives Rapid Dissemination of the Carbapenem Resistance Gene blaKPC The limits of serial surveillance cultures in predicting clearance of colonization with carbapenemase-producing Enterobacteriaceae.Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae at a single institution: insights into endemicity from whole-genome sequencing.Occurrence of OXA-48 Carbapenemase and Other β-Lactamase Genes in ESBL-Producing Multidrug Resistant Escherichia coli from Dogs and Cats in the United States, 2009-2013.Admission surveillance for carbapenamase-producing Enterobacteriaceae at a long-term acute care hospital.Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.Osteomyelitis due to multiple carbapenemase-producing Gram-negative bacteria: The first case report of a GES-13-producing Pseudomonas aeruginosa isolate in Canada.Cluster of Escherichia coli isolates producing a plasmid-mediated OXA-48 β-lactamase in a Spanish hospital in 2012.The world's microbiology laboratories can be a global microbial sensor network.Evaluation of a new phenotypic OXA-48 disk test for differentiation of OXA-48 carbapenemase-producing Enterobacteriaceae clinical isolates.Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.War wound treatment complications due to transfer of an IncN plasmid harboring bla(OXA-181) from Morganella morganii to CTX-M-27-producing sequence type 131 Escherichia coli.Carbapenemase-producing Enterobacteriaceae.Development of a novel real-time PCR assay with high-resolution melt analysis to detect and differentiate OXA-48-Like β-lactamases in carbapenem-resistant Enterobacteriaceae Genomically Informed Surveillance for Carbapenem-Resistant Enterobacteriaceae in a Health Care System Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.Prevalence of multidrug-resistant organisms in refugee patients, medical tourists and domestic patients admitted to a German university hospital.Elevated prevalence of multidrug-resistant gram-negative organisms in HIV positive men.Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods Antimicrobial Susceptibility of Klebsiella pneumoniae and Escherichia coli with Extended-Spectrum β-lactamase associated Genes in Hospital Tengku Ampuan Afzan, Kuantan, Pahang.Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.NBTI 5463 is a novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy.Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias.Carbapenem susceptibility breakpoints, clinical implications with the moving target.Acquired Class D β-Lactamases.Multidrug-resistant organisms in liver transplant: Mitigating risk and managing infections.OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014.Evaluation of the Carba NP Test in Oregon, 2013.NDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas.Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.In vivo horizontal gene transfer of the carbapenemase OXA-48 during a nosocomial outbreak.High Prevalence of β-lactamase and Plasmid-Mediated Quinolone Resistance Genes in Extended-Spectrum Cephalosporin-Resistant Escherichia coli from Dogs in Shaanxi, China.Multidrug-resistant bacteria in organ transplantation: an emerging threat with limited therapeutic options.

P2860

Q21131125-ED816003-469F-4941-988C-46888B1561F3 Q26744583-E4BFDF2D-F320-4481-AB2F-1F86135FED22 Q28078775-89BFC4D2-9C7E-4D9B-95C0-72E0001690D7 Q28545807-EFC35BB6-16B6-4F1C-9071-2A25BB6281E5 Q30276997-4C9852AD-7397-47E0-A3AF-BC65D8A86F79 Q30300357-F877610A-F296-4EE8-8A37-698B7CFA1C8C Q30301008-0776CA90-180C-4F82-AC28-6DE7BD5381C2 Q30391018-69A04BC9-5BF4-4B50-BFC4-DDF11E4B9C42 Q30456792-0993DAE0-8533-494E-B09B-3DAFEF956E9C Q30457566-8651FDF9-25E5-45FA-A4DE-2A1AEBF4D249 Q30458327-EBD5F938-E0F2-44FE-9B69-AE8B07499834 Q33797909-6AEBF966-932E-4A1A-8F7F-288EEDB42451 Q34238419-F9747ED7-8296-47C6-8A34-6D8712A2960C Q35035813-42D08E42-D0B3-43CE-9A17-24956A80B0F4 Q35091026-5B9BD553-ED81-44EB-9A02-7300E928DD71 Q35193334-C5685FF3-F73D-4D93-96EE-F21DE24E25F5 Q35297743-269DE629-B021-432E-8BD9-3D6FBD7ABADC Q35607676-C452715F-948A-4D60-911F-FBF14BFD0231 Q35751615-D8033463-7D54-40E3-B71B-4F0C3F5EFE70 Q35960962-9A63617B-2A72-4401-82E1-52C46D9A77FA Q36002662-E3DF5C4D-EF57-46E3-A6BD-8F6ACD03A22B Q36212092-FB05101B-4948-4506-BD37-E5A513C45A45 Q36240810-5C635825-44E5-4776-A105-A3C74B91718E Q36306571-5CA9B639-E5D2-4F90-88B9-ED24E13957D6 Q36631019-F7744806-741E-4591-8ADD-9F65B53271D1 Q37158193-D1262A97-70A9-4214-802F-4940C9D51BC3 Q37643634-3B05B4BE-E585-4A46-888D-777F6B86E1D6 Q37713025-5AD0CD3F-197A-4457-A60A-11A8CC87F757 Q38199187-0A098D9E-FC05-4CE2-A4BA-D0681C55C2B5 Q38267323-41ABCF4F-3024-4AC9-8468-D27354B4EB25 Q38751264-1C26702E-5EE8-4CA0-8700-B3C3A78587CF Q38792886-77C8E60C-8B0D-4EB2-A5E1-1CB6FD194B37 Q38845084-912EA6E8-AC7B-4D28-A268-13A1D2827260 Q38960250-C6015368-7725-43B3-92CD-B69483A2E3DA Q40033724-2DA4A7F1-21A5-4315-9CAE-8CF50E32BF50 Q40230679-DFB51743-37A8-42EE-AC36-538FB76A2F6B Q41042616-088A5A83-63D5-474A-B268-69A4D5EB87D9 Q41438717-4642234E-97D1-4F33-BBE9-C1E5784A4246 Q41789763-6D708799-3AA8-419D-904D-ADC3A731A8D5 Q42245248-A0C4D04A-344E-4292-B0FE-8F0D674E0746

P2860

First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world

http://www.wikidata.org/entity/Q30417939

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

First clinical cases of OXA-48 ...... nace" arrives in the new world

@ast

First clinical cases of OXA-48 ...... nace" arrives in the new world

@en

type

label

First clinical cases of OXA-48 ...... nace" arrives in the new world

@ast

First clinical cases of OXA-48 ...... nace" arrives in the new world

@en

prefLabel

First clinical cases of OXA-48 ...... nace" arrives in the new world

@ast

First clinical cases of OXA-48 ...... nace" arrives in the new world

@en

P1433

Q30417939-59271A80-8867-4B41-BD32-171E1BC17217

P1476

Q30417939-37D0C79F-D71D-4FFA-A3BB-9EFC8D17E707

P2093

Q30417939-3D1AEB09-D805-4AE7-B627-D65477AFC613

Q30417939-5CEB7D37-EC32-4897-BEE5-F7BCE01008FA

Q30417939-B10676F8-0257-4E5E-A96C-56CD6CFD3D1C

Q30417939-E414C9D9-4836-497E-B353-E74DC9759788

P2860

Q30417939-027AE8A7-E7EF-431C-B946-2DD134A9DCC4

Q30417939-19C88997-5D2D-4AD6-91DC-8D635EDFD316

Q30417939-3E9C1AFE-4F9D-4596-A3DD-20124D073AF1

Q30417939-52F549BB-1E20-4B51-9FD4-11C5753D97BF

Q30417939-54A3273A-8BFD-4042-A823-39D87A358183

Q30417939-6455BEE6-C8B5-4F59-A312-872D0EA9CFEC

Q30417939-6DB876C6-6542-4ACA-9C9D-070964D54F20

Q30417939-7F6F22AE-F880-47B0-BE51-F358EADF8667

Q30417939-B8F8BE7E-85F2-45A0-95D1-F93AF3A6FD41

Q30417939-C0137E4B-EFDB-4E0A-AADD-50131C6CD5D2

P304

Q30417939-13616E0C-C1FD-4EF0-B6C2-40D99C22CC9E

P31

Q30417939-D757A66C-C230-458A-9087-DFA247835A56

Q30417939-f2024b6f-36a6-4bdc-b184-563b91c586c8

P356

Q30417939-FF90E8D2-4A02-4BB3-90BE-A718BDDCDCAF

P407

Q30417939-89396A77-1AF3-4835-BA9F-4191606EB6E4

P433

Q30417939-B9D5E3F0-F5A2-4F5F-BE60-F0768C083C5C

P478

Q30417939-6A66A152-2698-41AC-931D-B7472F2D6D28

P50

Q30417939-59625CC3-AAB1-4269-99E0-D372DA4AED73

Q30417939-75190D2C-EED7-4377-8798-D930F7FAFDDF

Q30417939-B236372F-73DC-4962-8DCA-083104911C4D

P577

Q30417939-03B805D2-D3E4-49AF-92AF-96D5E6672D60

P5875

Q30417939-87CF2217-A04C-4485-BF3B-85C36FC8647D

P698

Q30417939-D9B1E455-28B4-4CC1-92F2-782697F97861

P921

Q30417939-4BCD7C39-D845-4F46-BDA3-129FF729B288

Q30417939-5A6A98B9-D7C7-453E-ABB1-34C2C59974B9

P932

Q30417939-67270C8B-B8F6-4327-AFCF-875F3F727199

P356

P1433

Journal of Clinical Microbiology

P1476

First clinical cases of OXA-48 ...... nace" arrives in the new world

@en

P2093

Anthony J Yeh

http://www.w3.org/2001/XMLSchema#string

Heather L Cox

http://www.w3.org/2001/XMLSchema#string

Joanne Carroll

http://www.w3.org/2001/XMLSchema#string

Kevin C Hazen

http://www.w3.org/2001/XMLSchema#string

P2860

Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients

Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae.

Global spread of Carbapenemase-producing Enterobacteriaceae

Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.

Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America.

OXA-48-like carbapenemases: the phantom menace.

The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae.

Genetic features of the widespread plasmid coding for the carbapenemase OXA-48.

Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae.

Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.

P304

680-683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.02580-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Costi David Sifri

Robert A Bonomo

P577

2012-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233750624

http://www.w3.org/2001/XMLSchema#string

P698

23175248

http://www.w3.org/2001/XMLSchema#string

P921

Klebsiella pneumoniae

carbapenem antibiotic

P932

3553872

http://www.w3.org/2001/XMLSchema#string